Morgan Henry 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Dec 15, 2009
Insider Transaction Report
Form 4
Morgan Henry
Director
Transactions
- Sale
Common Stock
2009-12-11$30.04/sh−11,254$338,090→ 32,274 total - Exercise/Conversion
Stock Option (Right to Buy)
2009-12-11−10,000→ 164,425 totalExercise: $1.00From: 2002-04-19Exp: 2011-04-18→ Common Stock, $.001 par value (10,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2009-12-11−10,000→ 174,425 totalExercise: $2.56From: 2005-06-05Exp: 2010-06-04→ Common Stock, $.001 par value (10,000 underlying) - Exercise/Conversion
Common Stock
2009-12-11$2.56/sh+10,000$25,630→ 33,528 total - Exercise/Conversion
Common Stock
2009-12-11$1.00/sh+10,000$10,000→ 43,528 total - Sale
Common Stock
2009-12-14$30.36/sh−200$6,071→ 32,074 total